Market Place
Sourcing Support
Jonathan Milner Appointed Non-Exec Chairman at Healx
03 Dec 2024 //
BUSINESSWIRE
Healx Partners with Sanofi to Explore Rare Disease AI Drug Discovery
13 Nov 2024 //
BUSINESSWIRE
Healx Raises $47M Series C And Gets FDA Clearance For NF1 Trial
01 Aug 2024 //
BUSINESSWIRE
Healx has new location at Chesterford Research Park
12 Jul 2022 //
PHARMATIMES
Ovid pens deal to offload twice-failed former lead program
09 Feb 2022 //
BIOSPACE
Healx receives IND and Orphan Drug Designation for fragile X clinical trial
20 Oct 2021 //
PRESS RELEASE
Healx approaches seminal US clinical trial milestone
08 Apr 2021 //
BUSINESSWEEKLY
Healx collaborates on Angelman syndrome therapies
20 Aug 2020 //
OUTSOURCING-PHARMA
Healx collaborates on Angelman syndrome therapies
18 Aug 2020 //
OUTSOURCING-PHARMA
Healx backs Rare Treatment Accelerator with $20m
25 Nov 2019 //
PHARMATIMES
Healx Secures $56M in Series B Financing
17 Oct 2019 //
BUSINESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.